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We have found that isolated rat hepatocytes and eel1 extracts catalyze the stoichiometric conversion of nitrite (either as a product of the oxidation 
of endogenously s nthesized nitric oxide or added as sodium nitrite) to nitrate, which in extracts requires the presence oftetrahydrobiopterin and 
1s inhibited by cyanide but apparently not by carbon monoxide. The reaction is sensitive to heat denaturation and does not involve oxidation of 
NO; by a peroxidative or radical oxygen mechanism. These results indicate the presence of a hitherto undescribed mammalian mechanism of 
morganic nitrogen oxide oxidation that may be a protective mechanism against one potentially damaging effect of endogenous ‘NO production 
(NO; formation), and also that assays of ‘NO formation based on NO; determination alone may be an inaccurate measurement of this activity. 
Nitric oxide; Nitrite; Tet~hydrobiopte~n; Nitrogen oxide 
1. INTRODUCTION 
Nitric oxide (‘NO) is a reactive radical molecule that 
IS important in a remarkable variety of physiological 
and pathophysiolo~~l processes [l-3]. Its roles in in- 
flammation and immune activation have been charac- 
terized as ‘double-edged’ because it participates in proc- 
esses that are both protective and damaging towards the 
host [4,5]. It is presently unclear what is the mechanistic 
basis that determines the damaging vs. protective ac- 
tions of ‘NO although it is likely that several factors are 
important, including the apparently limited diffusibility 
of ‘NO and consequently localized actions [6], the chem- 
ical conditions that dictate the nature of the reactions 
of “NO with oxygen species [7,8], the role of *NO as an 
endothelium-derived relaxing factor and thus control of 
localized vascular flow [9], and the possible existence of 
endogenous protective mechanisms against ‘NO toxic- 
ity [3,10,1 l]. 
Upon infla~ato~ stimulation either in vivo [IZ] or 
in vitro [13] ‘NO is synthesized in rodents by the liver 
in prodigious amounts. In vitro, hepatocyte ‘NO pro- 
duction results in several damaging effects, including 
inhibition of iron-containing enzyme function, specifi- 
cally aconitase and mitochondrial electron transfer 
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Abbreviations: B&, tetrahydrobiopterin; CM, cytokine mix, com- 
posed of a combination of rat recombinant interferon-y, recombinant 
human interleukin-l/3, and recombinant murine tumor necrosis factor- 
tr; EPR, electron paramagnetic resonance spectroscopy; LPS, lipopol- 
ysaccharide; NMMA, &‘9-monomethyl-L-arginine; NOS, nitric oxide 
synthase; NO;, total nitrogen oxides (NO; + NO;). 
[ 14,151. Nevertheless, *NO production by the hepato- 
cyte appears to be less detrimental to this cell than other 
cell types, such as the activated macrophage and its 
tumor cell targets 13,161. Especially in light of the host 
protective role that hepatic ‘NO production plays in in 
vivo inflammation-induced liver damage [17,18], it is 
reasonable to suggest that this cell may possess mecha- 
nisms for protection against the damaging effects of 
‘NO. 
Under biological conditions ‘NO is oxidized to pro- 
duce nitrite and nitrate [19]. Althou~ NO; is frilly oxi- 
dized and thus relatively unreactive, NO; can be toxic 
to cells and its damaging effects are in fact similar to 
those on ‘NO, its one electron reduction product 
[20,21]. Here we demonstrate the existence of a unique 
mammalian enzymatic mechanism for the detoxifica- 
tion of NO; in rat hepatocytes, a tetrahydrobiopterin- 
dependent oxidation of NO; to NO;. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Williams medium E, penicillin, and streptomycin were purchased 
from Grand Island Biological Co. (NY). Insulin was purchased from 
Eli Lilly Co. 5,6,7,8-tetrahydrobiopterin (BH,) was obtained from Dr. 
B. Schirks Laboratories (Jona, Switzerland). Percoll was obtained 
from Pharmacia (Piscataway, NJ). All other chemicals and proteins 
were purchased from Sigma (St. Louis, MO), unless indicated other- 
wise. 
2.2. Isolation of hepatocytes 
Hepatocytes were isolated from male Sprague-Dawley rats (Harlan 
Sprague-Dawley, Indianapolis, IN) weighing 200-300 g, using a mod- 
ification of the in situ collagenase (type IV, Sii) perfusion technique 
previously published [12]. Highly purified hepatocytes were obtained 
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from Percoll gradient centrifugatton by repeated ifferential centrifu- 
gation at 50 x g for 4 min to remove non-parenchymal cells. 
2.3. Cell culture and induction of ‘NO production 
Isolated cells were cultured in Williams medium E supplemented 
with 1 PM insulin, 2 mM L-glutamine, 10’ U/l penicillin, 100 mg/l 
streptomycin and 10% low endotoxin fetal calf serum (Hyclone Labo- 
ratories. Logan, UT) in a 100 x 15 mm petri dish at a density of 5 x lo6 
cells per plate for 10 h. For induction of nitric oxide synthase (NOS) 
activity, the hepatocytes were subsequently treated for 13 h with 100 
U/ml rat recombinant interferon-y (Amgen), 5 U/ml recombinant 
human interleukin-lg (Cistron), 500 U/ml recombinant mu&e tumor 
necrosis factor-a (Genzyme), and 10 ,&ml lipopolysaccharide (LPS) 
(E. coli 011 l:B4; Sigma) as described previously [IO]. This mixture is 
referred to as cytokine mix (CM) plus LPS. 
2.4. Preparation of crude cytosol 
Harvested hepatocytes were washed twice wtth ice-cold phosphate 
buffered saline containing protease inhibitors, 0.1 mM phenylmeth- 
ylsulfonyl fluoride, 5 &ml aprotinin, 5 .&ml pepstatin A, and 1 
fig/ml chymostatin. The cell suspension (5 x 10’ cells/ml) was homog- 
enized on ice in a glass homogenizer with a Teflon pestle for 3 min. 
The crude cytosol was obtained as the supematant from centrifuga- 
tion at 30.000 x g for 30 mm. 
2.5. Assays of enzyme activity 
2.5.1. ‘NO production by cultured hepatocytes pretreated with CM 
plus LPS 
Hepatocytes were isolated and pretreated as described above. After 
the addition of fresh medium not containing CM or LPS, at the 
indicated time points a 200 ~1 sample of the culture medium was 
withdrawn and mixed with 0.5 N NaOH (400~1) and 10% ZnSO, (400 
,&, and centrifuged at maximum speed in a microcentrifuge to remove 
protein. The supematant was used for measurement of NO; and NO;. 
2.5.2. NOS assay in hepatocyte xtract 
The reaction mixture conststed of 1 mM NADPH, 20 PM FAD, 20 
PM FMN, 0.5 mM BH,, 4 mM L-arginine, and 5 mM glutathione, in 
a final volume of 200 ,ul in 40 mM Tris-HCl, pH 7.7. The reaction was 
initiated by addition of cell extract (30 ~1) at 37°C and terminated at 
various times by addition of 400 ~1 of 0.5 N NaOH and 400 ~1 of 10% 
ZnSO,. After centrifugation, NO; and NO; were measured in the 
supematant. 
2.5.3. Nitrite oxidation activity 
For cultured hepatocyte assay, the cells were isolated and cultured 
as described above except 0.75 mM NG-monomethyl-L-arginine 
(NMMA) was added during the 13 h incubation f CM and LPS. At 
zero time, fresh medium without CM or LPS was added, containing 
85 PM NaNO, and NMMA. Medmm NO; and NO; was measured 
as described above. Nitrite oxidation activity in the hepatocyte xtract 
was assayed as described above for NOS activity in the extract, except 
that 56 mM NaNO, replaced in the L-arginine and the reaction was 
initiated by the addition of cell extract as described in the figure 
legends. The omission or addition of cofactors and inhibitors were as 
described in the figure legends. 
2.6. Measurement of NO, and NO; 
NO; and NO; in the culture medium and in the nitrite oxidation 
assay were measured as described previously [lo]. Total NO; in the 
reaction mixture and culture media was measured using an automated 
procedure based on the Griess reaction [22]. NO; alone was measured 
by adding an equal volume of Griess reagent and measuring absorb- 
ance at 550 nm. Protein concentration was measured by protein assay 
kit (P5656; Sigma) and all data were presented as the mean f standard 
error of the mean (S.E.M.). 
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3. RESULTS 
During the course of our on-going studies of the bio- 
chemical responses of isolated rat hepatocytes to the 
damaging effects of endogenous ‘NO formation, we 
have consistently noted variations in long-term cultures 
in the relative amounts of NO; and NO;, the products 
of ‘NO oxidation [23]. We thus investigated this system- 
atically by pretreating cultured hepatocytes with a com- 
bination of cytokines (interferon-y, interleukin-lj$ and 
tumor necrosis factor-a) plus lipopolysaccharide (CM 
plus LPS) for 13 h to induce endogenous ‘NO synthesis 
[13], and then at zero time the medium was replaced 
with fresh medium not containing CM or LPS and at 
various times thereafter assayed for NO; and NO;. As 
shown in Fig. lA, at early times (O-5 h) most of the 
product of ‘NO oxidation was NO;, but at longer times 
(549 h) 95% of the NO; was eventually converted to 
NOT, even after net nitrogen oxide synthesis had ceased. 
Thus, it appears that the predominant product of ‘NO 
oxidation initially is NO;, which is subsequently con- 
verted to NO;. As shown in Fig. lB, a similar con- 
version of NO; to NO; occurs in assays of nitric oxide 
synthase (NOS) activity in vitro using crude hepatocyte 
cell extract; oxidation of NO; under these conditions is 
considerably more rapid than the conversion in intact 
cells. A similar result has recently been reported for 
extracts of rat cerebellum producing ‘NO from the con- 
stitutive isoform of NOS [24]. 
To directly determine the presence of this unique ac- 
tivity, we assayed the conversion of added NO; to NO; 
by extract of hepatocytes pretreated with CM plus LPS 
(Fig. 2). In this experiment, the substrate for NOS (L- 
arginine) was replaced with NaNO,, precluding the en- 
zymatic synthesis of ‘NO. Nitrite disappearance and 
stoichiometric onversion to NO; (data not shown) in- 
deed occurs, and it requires the simultaneous presence 
of both extract and the mixture of cofactors utilized for 
A 
12 
l3 
Fig. 1. Time-course of NO; and NO; formation in hepatocyte culture 
(A) and in cytosol (B). (A) Cultured hepatocytes pretreated with CM 
plus LPS. Hepatocytes were isolated, pretreated with CM plus LPS, 
and NO; and NO; were determined as described in section 2. 
(0) Accumulation of NO; + NO; (NO;); (u) ratio of NO;-to- NO;. 
(B) NOS assay in hepatocyte xtract. NOS activity was assayed as 
described in section 2. (0). (0). and (A) indicate accumulation of NO;. 
NO;, and NO;. respectively. 
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Time (h) 
Fig. 2. Nitrite oxidation activity in the extract from hepatocytes stim- 
ulated with CM plus LPS. Nitrite oxidation activity was measured as 
described in section 2 in the presence (0) or absence (A) of the same 
cofactors as NOS assay in Fig. 1, except hat L-arginine was replaced 
by 56 mM NaNO, and 20 ,~l extract (2.5 mg protein/ml) was added. 
(0) and (0) denote NO; alone (no cofactors or extract) and NO; plus 
cofactors without extract, respectively. 
maximal NOS activity (BH,, NADPH, FAD, FMN, 
and glutathione). 
Fig. 3A presents the effects of a single deletion of each 
component of the cofactor mixture on nitrite oxidation, 
assayed at a single time point (2.5 h). It is clear that the 
essential cofactor for this activity is BH+ It is notewor- 
thy that small but significant oxidation of nitrite occurs 
in the extract in the absence of cofactors (as is also 
observed in Fig. 2) and that this activity is completely 
prevented by NADPH. However, NADPH is not inhib- 
itory when present along with the other cofactors (Fig. 
3A). The explanation for this effect is presently un- 
known. 
As also shown in this figure (Fig. 3B), the NO; oxi- 
dation is not inhibited by NG-monomethyl+arginine 
(NMMA), a potent inhibitor of NOS activity [25]. This 
demonstrates that the activity is probably not due to 
NOS, although the precise mechanism of inhibition of 
the enzyme by this compound has not been elucidated. 
Activity is inhibited by cyanide, an inhibitor of many 
heme-containing enzymes, but apparently not by car- 
bon monoxide. Thus, the activity may involve a he- 
moprotein(s) (see section 4). 
Since treatment of cells with cytokines induces a multi- 
tude of responses [26], we next examined whether this 
nitrite oxidation activity is induced in hepatocytes by 
CM plus LPS. As shown in Fig. 4, nitrite oxidation 
activity is present in hepatocytes (A) and extract (B) 
whether or not they have been pretreated with CM plus 
LPS. This rules out NOS or the induction of other 
responses of these inflammatory mediators (such as the 
acute phase response [27]) as responsible for this activ- 
ity. 
4. DISCUSSION 
We demonstrate here the presence in isolated rat 
hepatocytes of a tetrahydrobiopterin-dependent activity 
that oxidizes NO; to NO;. The requirement for a reduc- 
tant (BH,) for an oxidative reaction (NO; to NO,) indi- 
cates the involvement of a mixed-function oxidation 
reaction, a class of reaction that is known to be abun- 
dantly present in the liver and is catalyzed principally 
by the cytochrome P45O’s [28]. However, to the best of 
our knowledge this is the first report of a BH,- depend- 
ent oxidation of inorganic nitrogen oxides. The inhibi- 
tion by cyanide indicates the involvement of a hemopro- 
tein(s), although no inhibition was observed with car- 
bon monoxide. This insensitivity to CO may indicate 
that the putative hemoprotein(s) is only transiently 
present in the reduced ferrous state during catalytic 
turnover that is required for sensitivity to this inhibitor. 
However, at this stage this result precludes the definitive 
assignment of the activity to a hemoprotein- catalyzed 
activity. 
Is this reaction a result of a specific mammalian ni- 
trite oxidase enzyme(s)? Two previous reports have de- 
scribed oxygen uptake upon addition of NO; to cyto- 
chrome oxidase [29,30], indicating oxidation of the 
NO;. However, this activity required very high concen- 
trations of NO; (0.5 M and higher). We find no detect- 
able oxidation of nitrite under our conditions by cyto- 
chrome oxidase (50 U/ml) in either the presence or ab- 
sence of BH,. Hoppel and Porterheld demonstrated ni- 
trite oxidation in rat liver homogenates with the addi- 
tion of no further cofactors and attributed the activity 
to a coupled reaction requiring an unidentified perox- 
idative activity and catalase [31], which was verified 
subsequently by Chance [32]. A similar reaction is also 
catalyzed by certain other hemoproteins in the presence 
of HzOz, including horseradish peroxidase [33,34] and 
metmyoglobin [33]. Roediger and Radcliffe also dem- 
onstrated nitrite oxidation by isolated rat colonocytes 
Fig. 3. Effects of single cofactor addition and NMMA and iron ligands 
on nitrite oxidation activity. (A) Cofactor specificity. Cofactor con- 
centration and experimental conditions were as described in Fig. 2 
except hat incubation was for 2.5 h and 40 ,ul cell extract was added. 
(B) Ligand effects. The assay was performed as described above, 
except only extract and NaNO, were added, in the absence or presence 
of 0.5 mM BFL, 0.5 mM NMMA, or 2 mM KCN. For CO treatment, 
the mixture was bubbled with pure CO gas for 5 s after 10 and 40 min 
of reaction at 37°C. 
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Fig. 4. Effect of pretreatment with CM + LPS on nitrite oxidation 
activity. (A) Cultured hepatocytes. Nitrite oxidation activity was de- 
termined as described in section 2 utilizing hepatocytes pretreated in 
the presence (0) or absence (0) of CM plus LPS. Also shown is 
medium alone without hepatocytes (0). (B) Hepatocyte xtract. Nitrite 
oxidation activity m the extract from hepatocytes (40 ~1) pretreated 
in the presence or absence of CM plus LPS was assayed as described 
in section 2. 
[35]. In light of the observation that, under some condi- 
tions, BH, can be oxidized to produce H202 [36], this 
raises the possibility that the activity we observe is due 
to such a mechanism. However, we find that H,O, (0.5 
mM) cannot replace BH, in the assay of hepatocyte 
extract nitrite oxidation activity, and that addition of 
catalase (400 U/200 ~1) does not affect the reaction. In 
addition, BH, or H202 plus catalase (900 U/ml) in the 
absence of hepatocyte extract does not result in NO, 
oxidation under our conditions. Other potential non- 
enzymatic mechanisms involving reactive oxygen inter- 
mediates (similar to the demonstration of the oxidation 
of ammonia to nitrate and nitrite [37-391) are unlikely 
also, since the reaction catalyzed by hepatocyte extract 
is not inhibited by the addition of allopurinol (50 yM) 
or the combination of catalase (400 U/200 ~1) and su- 
peroxide dismutase (150 mu/200 ~1). NO; is also not 
oxidized by xanthine oxidase plus hypoxanthine either 
in the absence or presence of iron-EDTA (10 mM) as 
a Fenton reagent, as reported previously [39]. These 
conditions have been shown previously to generate sub- 
stantial amounts of strongly oxidizing species [40]. Fi- 
nally, the activity is completely inactivated by heat de- 
naturation (100°C for 5 min). These results indicate that 
the activity may be due to a novel enzyme, although 
such a conclusion must await further studies. 
Nitrite is the one-electron oxidation product of ‘NO, 
and thermodynamically this couple (next to the oxida- 
tion of ‘NO, to NO;) is the most readily reversible 
among the 8 oxidation steps of the nitrogen oxides [41]. 
Thus, in the heterogenous environment of the intracel- 
lular cell compartment containing both abundant re- 
ductants and oxidants (02,*02-, H,O,), interconversion 
between ‘NO and NO; might be common in the absence 
of specific mechanisms for the removal of NO;. Indeed, 
NO; is damaging to several hepatic cell functions such 
as drug metabolism [42], and it has also been shown that 
under some conditions, NO; is reduced to ‘NO by mito- 
chondria and cytochrome P45O’s, which can result in 
auto-inactivation of the cytochrome P45O’s and ni- 
trosylation of essential heme-containing proteins such 
as cytochrome c [42,43]. In addition, abundant studies 
in the nutrition literature have demonstrated the reac- 
tions of NO; with biomolecules [44], and using electron 
paramagnetic resonance (EPR) spectroscopy we have 
presented evidence that this effect may be a consequence 
of ‘NO production in a reducing environment hat re- 
sults in destruction of iron-containing enzyme function 
[20]. Since we [45] and others [46,47] have described 
EPR evidence of a similar damage to iron- containing 
proteins during the endogenous production of ‘NO by 
NOS (necessarily occurring in the presence of 0, since 
this is a required substrate for NOS activity), this raises 
the possibility that a significant portion of the cytotoxic 
effector mechanism of NOS induction under inflamma- 
tory and immune activation conditions may be due to 
‘NO both newly produced by this enzyme and also by 
reduction of NO;. As has been speculated previously by 
Stuehr and Nathan [48], it may be that this is a mecha- 
nism that contributes to the destruction of phagocytized 
intracellular pathogens by the macrophage since the 
internal pH of the phagolysosome is acidic (pH 5.8 [49]), 
a condition known to facilitate the non-enzymatic de- 
composition of HNOI, to ‘NO and ‘NOI, with conse- 
quent cellular toxicity [50]. Indeed, Klebanoff [51] has 
recently demonstrated the bacteriostatic potential of 
NO; under acidic conditions, and provided evidence 
under certain conditions for a potentiation of this toxic 
effect with H202, which is also a product of phagocytic 
activation. In addition, evidence also suggests that at 
least two pathogenic organisms (Plasmodium falciparum 
[52] and Crytococcus neoformans [53]) are sensitive to 
NO;, under conditions that mimic those when phago- 
cytyzed by the macrophage. 
In a very recent report, Ignarro et al. [24] have dem- 
onstrated that the immediate product of the oxidation 
by O2 of ‘NO newly produced by cerebellar NOS is 
NO;, which is also true for pure ‘NO in aqueous solu- 
tion [B]. Gradual conversion of NO; to NO; is catalyzed 
by cellular components in crude extracts (but not by 
preparations more purified for NOS activity), as well as 
by added ferrohemoproteins (as has been documented 
previously [54]). The results presented here may offer an 
enzymatic explanation for this result, namely, a BH,- 
dependent nitrite oxidation activity that is removed 
upon further purification of NOS. These results and 
those presented here suggest hat assay of NOS activity 
in intact cells and extracts by measuring only NO; may 
give an incomplete indication of total ‘NO production, 
especially under conditions where cellular BH, and fer- 
rohemoproteins are variable. It is noteworthy that a 
similar nitrite oxidation was not observed by Ignarro et 
al. in an activated rat macrophage cell line, supporting 
the suggestion by Stuehr and Nathan that NO;, as well 
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as ‘NO, is important to macrophage-mediated immune 
defense mechanisms. Thus, the presence or absence of 
this nitrite oxidation activity in specific cell types may 
correlate with the cellular toxic vs. messenger roles of 
‘NO. Further characterization of this unique activity is 
under way. 
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